STATEWIDE — New York Attorney General Letitia James’ office has helped to secure a multistate settlement in principle with the successor company of pharmaceutical manufacturer Mylan Inc. that will ...
Israel's Teva Pharmaceutical Industries ($TEVA) is reported to be considering a $34 billion takeover of British-based Mylan ($MYL). But if it indeed is, the takeover ...
Theravance Biopharma (NASDAQ:TBPH) and partner Mylan reached a settlement agreement with Eugia Pharma over a patent dispute concerning the lung disease treatment, Yupelri inhalation solution. The ...
Apart from the Revlimid loss, generic price competition in the US, and the addition of new medical representatives in the ...
Theravance Biopharma (NASDAQ:TBPH) and Mylan unit of Viatris (NASDAQ:VTRS), reached a settlement agreement with India's Eugia Pharma over a patent dispute concerning the lung disease treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results